The Meadows lab presented posters at TRICS 2025!
15th International HHT Scientific Conference
Many members of the Meadows lab had the pleasure to attend the international conference hosted by Cure HHT, which brings together researchers, patients, and physicians!
Shreya, Adella, and Anirban presented posters.
All three graduate students were awarded Young Investigator Travel Funding.
Stryder and Shreya were invited to give presentations on ANG2 and ANG2/VEGF inhibition, respectively, to rescue AVM formation in HHT mouse models.
Adella was invited to give a data blitz introducing the new LOH mouse model, and she won Best Basic Science Poster Award!
Rajan has successfully defended his PhD Thesis!
Rajan is the fourth Meadows lab graduate student to defend their PhD thesis.
He was co-mentored by Dr. Meadows and Dr. Maria Galazo.
Rajan defended his research titled “The Functional and Molecular Role of Transcription Cofactor, ZMIZ1 in the Cerebral Cortex and Lymphatic Endothelial Cell” on April 02, 2024.
NEW PAPER!!
Rajan K C has published his paper titled “Zmiz1 is a novel regulator of lymphatic endothelial cell gene expression and function”. CHECK IT OUT!
TRICS Poster 2024
Two members of Meadows lab won awards for their poster presentations at the Second Annual Tulane Research, Innovation, and Creativity Summit, TRICS, 2024.
Adella Guidroz was awarded the Graduate Student Best Poster Award for the second year in a row.
Andrew Hancock was awarded the Undergraduate Student Best Poster Award!
This was his first ever poster presentation, and we are proud of this accomplishment!
New Paper!!!
Rajan K C has published his paper titled “Zmiz1 is a novel regulator of brain development associated with autism and intellectual disability”. Check it out!
Shreya and Adella received funding through the NIH
Both doctoral candidates were awarded F31 funding for two years for their respective projects!
Adella’s project titled “Evaluating the Impact of Loss of Heterozygosity on Localized AVM Formation in HHT” uses a new mouse model to better represent patient genotype and monitor disease progression.
Shreya’s project entitled “Uncovering the Combined Effects of VEGFA and ANG2 Pro-Angiogenic Signaling in Hereditary Hemorrhagic Telangiectasia” utilizes a dual VEGF/ANG2 bi-specific inhibitor to uncover potential synergism between these two pathways.
CMB Retreat 2023
Congrats to Adella for earning 2nd place for her platform presentation at the 2nd annual Tulane CMB Retreat!
Vasculata 2023
The Meadows Lab overtook Vasculata 2023!!!
TRICS Poster 2023
Adella and Shreya each won first prize for their poster presentations at the First Annual Tulane Research, Innovation, and Creativity Summit, TRICS, 2023.
CMB Retreat 2022
Rajan won the first prize for poster presentation at the annual departmental retreat, 2022.
Nehal Patel successfully defended his PhD thesis on August 2, 2022: Congrats Dr. Patel!
Nehal is the third Meadows lab graduate student to defend their PhD thesis.
Nehal defended his research titled “Novel Role of PRR and Zmiz1 in Physiological and Pathological Angiogenesis”.
Xingyan Zhou successfully defends her PhD thesis: congrats Dr. Zhou!
Xingyan is the second Meadows lab graduate student to defend their PhD thesis.
Meadows Lab Receives Multi-PI NIH R01 Grant!
This 4 year NIH/NHLBI Award with Philippe Marambaud aims to assess the role of Ang2-TIE2 signaling in AVM pathogenesis association with HHT.
Xingyan receives an Outstanding Poster Award at NAVBO's 2020 Vascular Biology meeting.
Congratulations, Xingyan!
Xingyan Zhou is awarded an AHA predoctoral fellowship
Congratulations to Xingyan for being awarded the AHA predoctoral fellowship!!
Check out our latest paper in Circulation!
Angela Crist successfully defends her PhD thesis: congrats Dr. Crist!
Angela is the first Meadows lab graduate student to defend their PhD thesis.
Meadows lab takes over NAVBO's 2018 Vascular Biology meeting in Newport, RI
Nehal, Dawn and Xingyan at the poster presentations!
Meadows lab receives its first NIH R01 grant!
This 5 year, $1.82 million dollar NIH/NHLBI award will be used to investigate TGF-Beta downstream effectors involved in AVM formation tied to Hereditary Hemorrhagic Telangiectasia (HHT).
